Moors & Cabot, Inc. - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLP and the CUSIP is 81369Y308. A total of 435 filers reported holding SELECT SECTOR SPDR TR in Q4 2014. The put-call ratio across all filers is 8.28 and the average weighting 0.9%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$485,088
-9.3%
7,050
-2.2%
0.03%
-5.7%
Q2 2023$534,587
-10.2%
7,208
-9.5%
0.04%
-14.6%
Q1 2023$595,210
+2.9%
7,967
+2.7%
0.04%
+2.5%
Q4 2022$578,381
+8.9%
7,758
-2.6%
0.04%0.0%
Q3 2022$531,000
-18.6%
7,963
-11.9%
0.04%
-14.9%
Q2 2022$652,000
+10.3%
9,040
+16.2%
0.05%
+30.6%
Q1 2022$591,000
+9.4%
7,783
+11.1%
0.04%
+9.1%
Q4 2021$540,000
+20.3%
7,005
+7.0%
0.03%
+17.9%
Q3 2021$449,000
-3.4%
6,545
-1.5%
0.03%
-15.2%
Q2 2021$465,000
+2.9%
6,642
-0.0%
0.03%
-5.7%
Q1 2021$452,000
+6.9%
6,644
+5.7%
0.04%
-2.8%
Q4 2020$423,000
-2.5%
6,285
-7.2%
0.04%
-12.2%
Q3 2020$434,000
-8.6%
6,771
-16.6%
0.04%
-19.6%
Q2 2020$475,000
+7.7%
8,116
-0.1%
0.05%
-20.3%
Q1 2020$441,000
+83.8%
8,124
+111.2%
0.06%
+166.7%
Q4 2019$240,000
-14.6%
3,847
-26.2%
0.02%
-29.4%
Q3 2018$281,000
+6.0%
5,212
+5.0%
0.03%
-22.7%
Q3 2016$265,000
+6.4%
4,966
+9.5%
0.04%0.0%
Q2 2016$249,000
+3.3%
4,536
-7.9%
0.04%
+10.0%
Q1 2015$241,000
-2.8%
4,924
-3.4%
0.04%
-4.8%
Q4 2014$248,000
-17.9%
5,099
-24.9%
0.04%
-17.6%
Q2 2014$302,0006,7930.05%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q4 2014
NameSharesValueWeighting ↓
WFA Asset Management Corp 332,708$22,893,64213.68%
Valence8 US LP 243,743$16,771,95610.61%
CVS HEALTH Corp 281,400$19,363,13410.35%
WestEnd Advisors, LLC 3,181,757$218,936,6826.58%
Granite Bay Wealth Management, LLC 8,919,693$652,8226.41%
Client First Capital LLC 118,618$8,162,0895.91%
Conservest Capital Advisors, Inc. 685,607$47,176,6095.69%
Spectrum Wealth Advisory Group, LLC 59,167$4,071,2895.63%
Quantitative Investment Management, LLC 509,466$35,0565.39%
Biltmore Wealth Management, LLC 156,718$10,783,7495.21%
View complete list of SELECT SECTOR SPDR TR shareholders